A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease
Top Cited Papers
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41 (3) , 565-570
- https://doi.org/10.1053/ajkd.2003.50140
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- Recent advances in statins and the kidneyKidney International, 1999
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapyThe Journal of Pediatrics, 1997
- Effects of Hypercholesterolemia on Renal Hemodynamics: Study in Patients with Nephrotic SyndromeNephron, 1996
- Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatinKidney International, 1995
- Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitroThe American Journal of Cardiology, 1995
- Apolipoprotein-B-Containing Lipoproteins and the Progression of Renal InsufficiencyNephron, 1993
- LDL stimulates mesangial fibronectin production and chemoattractant expressionKidney International, 1993
- Lipoprotein distribution and composition in the human nephrotic syndromAtherosclerosis, 1985